Next Article in Journal
Comparative Bioavailability of Synthetic B12 and Dietary Vitamin B12 Present in Cow and Buffalo Milk: A Prospective Study in Lactovegetarian Indians
Previous Article in Journal
The Reasons for Doing Physical Exercise Mediate the Effect of Self-Esteem on Uncontrolled Eating Amongst Nursing Personnel
Open AccessArticle

Weight Gain and Liver Steatosis in Patients with Inflammatory Bowel Diseases

1
Department of Clinical and Experimental Medicine, University Magna Grecia, 88100 Catanzaro, Italy
2
Department of Medical and Surgical Science, Nutrition Unit, University Magna Grecia, 88100 Catanzaro, Italy
3
Department of Molecular and Clinical Medicine, University of Gothenburg, 40530 Gothenburg, Sweden
*
Author to whom correspondence should be addressed.
Nutrients 2019, 11(2), 303; https://doi.org/10.3390/nu11020303
Received: 28 December 2018 / Revised: 25 January 2019 / Accepted: 28 January 2019 / Published: 1 February 2019
Background and Aim: Most studies focused on the benefits of weight loss on hepatic steatosis and no studies have been specifically designed to assess the role of weight gain on the development of liver steatosis in patients affected by inflammatory bowel diseases. The aim of this study was to analyse the relation between weight change over time and liver steatosis in patients with inflammatory bowel diseases. Methods: We retrospectively evaluated a population of 89 ambulatory patients in clinical remission or affected by mild disease, as determined from disease activity indices, with at least one follow-up visit. Transient elastography was used to quantify liver steatosis. Results: A total of 49 individuals (55%) were overweight/obese at baseline. A significant difference in weight change was found between participants that improved, were stable and worsened, over a mean follow-up of four years. (−1.0 kg ± 4; 2.5 kg ± 6; and 5.4 kg ± 5; respectively, p = 0.009). We found a greater probability of worsening in the hepatic fat content in individuals who gained more than 6% of body weight than in those gaining less than this value (log–rank (Mantel–Cox) χ2 test = 9.85; df = 1; p = 0.002). Conclusions: A body weight gain of 6% increases the probability of deterioration in liver steatosis over a period of four years in patients with inflammatory bowel diseases. Weight gain prevention with lifestyle interventions may be the cornerstone treatment of these patients. View Full-Text
Keywords: inflammatory bowel diseases; weight gain; hepatic steatosis; transient elastography inflammatory bowel diseases; weight gain; hepatic steatosis; transient elastography
Show Figures

Figure 1

MDPI and ACS Style

Spagnuolo, R.; Montalcini, T.; De Bonis, D.; Ferro, Y.; Cosco, C.; Mazza, E.; Romeo, S.; Doldo, P.; Pujia, A. Weight Gain and Liver Steatosis in Patients with Inflammatory Bowel Diseases. Nutrients 2019, 11, 303.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop